Bariatric Support Groups Predicts Long-term Weight Loss
Related Experiment Video
Updated: Dec 29, 2025

Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
Alba Andreu1, Amanda Jimenez1,2,3, Josep Vidal1,2,4
1Obesity Unit, Hospital Clinic Barcelona, Villarroel 170, 08036, Barcelona, Spain.
Background:
Support groups are an integral part of bariatric surgery (BS) programs yet there is limited evidence for an association between support group attendance and BS weight outcomes.
Settings:
University Hospital, Spain.
Objectives:
This study examined the effect of support group attendance on weight loss (WL) at short- and long-term follow-up (FU) following BS.
Methods:
Participants were 531 (mean body mass index (BMI) = 45.8 (5.4) kg/m2; mean age 45.9 (11.1) years, 76.4% females) who underwent BS (Roux-en-Y gastric bypass (RYGB): 233 (43.8%); sleeve gastrectomy (SG): 298 (56.2%)) in our clinic. The bariatric support group program (BSGP) consisted of two subprograms: Novel-BSGP (N-BSGP; first 12 months after surgery) and Experienced-BSGP (E-BSGP; FU between 12 months 5 years after BS).
Results:
Three hundred and twenty-three (60.8%) and 129 (24.3%) participants attended at least one session of N-BSGP and E-BSGP, respectively. Linear regression analyses showed that number of sessions attended during year 1 predicted percent total body WL (%TBWL (β = 0.381, p < 0.001)) and percent excess WL (%EWL (β = 0.928, p < 0.001)) at one year and number of sessions attended during years 2-5 were positively related to %TBWL and %EWL achieved at 5 years (%EWL: β = 0.162 (p = 0.014) and %TBWL: β = 0.378 (p = 0.013)) respectively.
Conclusion:
We observed a significant beneficial effect of a post-surgical support group program on short- and long-term body WL after BS.
Related Concept Videos
Binge Eating Disorders
Obesity
Self-Help Support Groups
Accessibility and Cost-Effectiveness
One of the primary strengths of self-help...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Drug Dosing: Obese Patients
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

